KC
DGX icon

KHP Capital’s Quest Diagnostics DGX Stock Holding History

KHP Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$76K Hold
700
– – 0.05% 94
2018
Q2 		$77K Hold
700
– – 0.05% 92
2018
Q1 		$70K Buy
+700
New +$71.7K 0.05% 95

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

KHP Capital's DGX Position: Q3 2018 in Review

KHP Capital held its Quest Diagnostics (DGX) position steady in Q3 2018 at 700 shares worth $76K. The position accounts for 0.05% of the portfolio, ranked #94.

KHP Capital first reported a position in DGX in Q1 2018 and has held it in 3 quarters since. The position peaked at $77K in Q2 2018. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • KHP Capital held 700 shares of Quest Diagnostics worth $76K as of Q3 2018.
  • KHP Capital left its Quest Diagnostics share count unchanged in Q3 2018.
  • Quest Diagnostics made up 0.05% of KHP Capital's portfolio in Q3 2018, its #94 holding.
  • KHP Capital first reported a position in Quest Diagnostics in Q1 2018 and has held it in 3 quarters since.
  • KHP Capital's Quest Diagnostics position peaked at $77K in Q2 2018.
  • 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.